Abstract
PGE2 inhibits fetal breathing movements (FBM); the prostaglandin synthetase inhibitor, M, stimulates FBM. To determine if these effects are mediated through the peripheral chemoreceptors, we studied 13 chronically catheterized fetuses; 7 had bilateral sections of carotid sinus and vagus nerves; 6 had sham operations. FBM (by tracheal catheter) and electrocortical activity (ECoA) were recorded continuously. After a control (C) period (19.9±4.5h; mean±SD) we infused PGE2 (0.6±0.2 μg/kg/min) or M (0.4±0.2 mg/kg/h) for 20.0±2.1 h per infusion. Infusions were separated ≥ 48 h. The incidences and amplitudes of FBM were lower in the denervated group (Table).
(values=mean±SD; °P<0.05 compared to C; ¶P<0.05 compared to Sham). However, the % change from C during infusions was similar in both groups as were the ECoA, arterial pH, PO2, PCO2 and pressures. We conclude that peripheral chemoreceptor denervation significantly affects FBM; however the effects of PGE2 and M on FBM are not mediated through the peripheral chemoreceptors. (USPHS HL-27356).
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mural, D., Lee, C., Wallen, L. et al. THE EFFECTS OF PROSTAGLAN DIN E2 (PGE2) AND MECLOFENAMATE (M) IN BREATHING MOVEMENTS IN FETAL SHEEP ARE NOT MEDIATED THROUGH PERIPHERAL CHEMORECEPTORS. Pediatr Res 18 (Suppl 4), 400 (1984). https://doi.org/10.1203/00006450-198404001-01841
Issue Date:
DOI: https://doi.org/10.1203/00006450-198404001-01841